⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6938451 | 0.97 | — | — | |
| Pyrrolidine SCHEMBL16620606 | 0.86 | ALDH1A1 (0.40) | — | |
| SCHEMBL1013568 | 0.69 | — | — | |
| SCHEMBL1782493 | 0.67 | — | — | |
| SCHEMBL148995 | 0.67 | — | — | |
| Hydrochloric Acid SCHEMBL4973373 | 0.65 | — | — | |
| SCHEMBL6203044 | 0.65 | — | — | |
| Iodide SCHEMBL7404077 | 0.65 | — | — | |
| SCHEMBL1780706 | 0.63 | HIF1A (0.33) | — | |
| SCHEMBL1782169 | 0.63 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5291 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117143332-B | Preparation method of corrosion inhibitor for oilfield sewage containing sulfate reducing bacteria | 东营市百扬石油科技有限责任公司 | 2024-01-02 | — | — | CN | claimed |
| CN-117143332-A | Preparation method of corrosion inhibitor for oilfield sewage containing sulfate reducing bacteria | 东营市百扬石油科技有限责任公司 | 2023-12-01 | — | — | CN | claimed |
| WO-2023202175-A1 | NATURALLY BALANCED ULTRA-HIGH CONCENTRATION MULTIPLE AND ZERO EMISSION CONTROL METHOD FOR CIRCULATING COOLING WATER SYSTEM | 天津正达科技有限责任公司 | 2023-10-26 | — | — | WO | claimed |
| US-11697884-B2 | Copper deposition in wafer level packaging of integrated circuits | MACDERMID ENTHONE INC. (US) | 2023-07-11 | — | — | US | claimed |
| CN-115583958-A | Synthesis method of dihydrothia (oxa) zole [3',2':1,5] dihydroimidazole [4,5-b ] piperidine derivative | 河南师范大学 | 2023-01-10 | — | — | CN | claimed |
| CN-110494219-B | Cyclically supported catalyst | 巴黎萨克雷大学 | 2022-10-28 | — | — | CN | claimed |
| CN-114853240-A | Natural balance ultrahigh concentration multiple and zero discharge control method for circulating cooling water system | 天津正达科技有限责任公司 | 2022-08-05 | — | — | CN | claimed |
| US-20220177462-A1 | SUBSTITUTED HETEROCYCLIC AMIDE COMPOUND AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF | GENFLEET THERAPEUTICS (SHANGHAI) INC. (CN) | 2022-06-09 | — | — | US | claimed |
| CN-114420633-A | Copper deposition in wafer level packaging of integrated circuits | 麦克德米德乐思公司 | 2022-04-29 | — | — | CN | claimed |
| EP-3943488-A1 | SUBSTITUTED HETEROCYCLIC AMIDE COMPOUND AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF | Genfleet Therapeutics (Shanghai) Inc. (CN) | 2022-01-26 | — | — | EP | claimed |
| US-20040038969-A1 | Vanilloid receptor ligands and their use in treatments | AMGEN, INC. | 2004-02-26 | — | — | US | claimed |
| WO-2004014871-A1 | VANILLOID RECEPTOR LIGANDS AND THEIR USE IN TREATMENTS | AMGEN INC. (US) | 2004-02-19 | — | — | WO | claimed |
| EP-1381598-A1 | NOVEL TYROSINE KINASE INHIBITORS | Bristol-Myers Squibb Company (US) | 2004-01-21 | — | — | EP | claimed |
| WO-2003099284-A1 | AMINO-PYRIDINE, -PYRIDINE AND PYRIDAZINE DERIVATIVES FOR USE AS VANILLOID RECEPTOR LIGANDS FOR THE TREATMENT OF PAIN | AMGEN INC. (US) | 2003-12-04 | — | — | WO | claimed |
| US-20030195201-A1 | Vanilloid receptor ligands and their use in treatments | AMGEN INC. | 2003-10-16 | — | — | US | claimed |
| WO-2003049702-A2 | VANILLOID RECEPTOR LIGANDS AND THEIR USE IN TREATMENTS | AMGEN INC. (US) | 2003-06-19 | — | — | WO | claimed |
| WO-2002079192-A1 | NOVEL TYROSINE KINASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2002-10-10 | — | — | WO | claimed |
| US-5919811-A | NEURODEGENERATIVE DISORDERS | GLAXO WELLCOME S.P.A. (IT) | 1999-07-06 | — | — | US | claimed |
| EP-0583820-A1 | Novel carbamazepine hapten analogues | Johnson & Johnson Clinical Diagnostics, Inc. (US) | 1994-02-23 | — | — | EP | claimed |
| US-5138067-A | PAF antagonists, antithrombotic, antivasoconstricting, antibronchoconstricting or antitumor agents | SHIONOGI & CO. LTD. (JP) | 1992-08-11 | — | — | US | claimed |